MGRX Stock Price | Mangoceuticals, Inc. Common Stock P/E, Revenue, EPS, & Forecasts

Mangoceuticals, Inc. Common Stock • MGRX

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Mangoceuticals, Inc. Common Stock

Ticker

MGRX

Trading on

NASDAQ

ISIN

US56270V2051

Industry

Health Information Services

Sector

Healthcare

CEO

Jacob D. Cohen

Headquarters

15110 N. Dallas Parkway, Dallas, TX, United States, 75248

Employees

Website

mangoceuticals.com

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Metrics

BasicAdvanced

Market cap

$14.1M

P/E ratio

EPS

-$2.72

Dividend Yield

0.00%

Beta

2.39

Forward P/E ratio

EBIDTA

$-16.5M

Ex dividend date

Price & volume

Market cap

$14.1M

Average daily volume

3.8M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

36.63

Price to book

1.03

Earnings

EPS

-$2.72

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-16.5M

Revenues (TTM)

$0.5M

Revenues per share (TTM)

$0.07

Technicals

Beta

2.39

52-week High

$6.15

52-week Low

$0.98

50-day moving average

$1.95

200-day moving average

$2.21

Short ratio

0.57

Short %

15.38%

Management effectiveness

ROE (TTM)

-136.16%

ROA (TTM)

-73.79%

Profit margin

0.00%

Gross profit margin

$0.3M

Operating margin

-8,913.90%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

-36.80%

Share stats

Outstanding Shares

11.4M

Float

10.1M

Insiders %

28.44%

Institutions %

2.69%

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$1.08

Q4 • 24Beat

-$1.05

Q1 • 25Beat

-$0.57

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0.2M

$-5.4M

-3,221.61%

Q2 • 25

$0.1M

$-7.6M

-9,042.82%

Q3 • 25

-49.89%

40.67%

180.69%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$20.8M

$1.6M

7.68%

Q2 • 25

$16.5M

$0.8M

4.87%

Q3 • 25

-20.68%

-49.76%

-36.66%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-1.3M

$1.3M

$-1.3M

Q2 • 25

$-1.2M

$0M

$1.6M

$-1.2M

Q3 • 25

-1.21%

26.61%

-1.21%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Mangoceuticals, Inc. Common Stock share?

Mangoceuticals, Inc. Common Stock shares are currently traded for undefined per share.

How many shares does Mangoceuticals, Inc. Common Stock have?

Mangoceuticals, Inc. Common Stock currently has 11.4M shares.

Does Mangoceuticals, Inc. Common Stock pay dividends?

No, Mangoceuticals, Inc. Common Stock doesn't pay dividends.

What is Mangoceuticals, Inc. Common Stock 52 week high?

Mangoceuticals, Inc. Common Stock 52 week high is $6.15.

What is Mangoceuticals, Inc. Common Stock 52 week low?

Mangoceuticals, Inc. Common Stock 52 week low is $0.98.

What is the 200-day moving average of Mangoceuticals, Inc. Common Stock?

Mangoceuticals, Inc. Common Stock 200-day moving average is $2.21.

Who is Mangoceuticals, Inc. Common Stock CEO?

The CEO of Mangoceuticals, Inc. Common Stock is Jacob D. Cohen.

How many employees Mangoceuticals, Inc. Common Stock has?

Mangoceuticals, Inc. Common Stock has 3 employees.

What is the market cap of Mangoceuticals, Inc. Common Stock?

The market cap of Mangoceuticals, Inc. Common Stock is $14.1M.

What is the P/E of Mangoceuticals, Inc. Common Stock?

The current P/E of Mangoceuticals, Inc. Common Stock is null.

What is the EPS of Mangoceuticals, Inc. Common Stock?

The EPS of Mangoceuticals, Inc. Common Stock is -$2.72.

What is the PEG Ratio of Mangoceuticals, Inc. Common Stock?

The PEG Ratio of Mangoceuticals, Inc. Common Stock is null.